Tag

Warburg Pincus

All articles tagged with #warburg pincus

mergers-and-acquisitions17 days ago•4 min saved

PE suitors circle Canaccord UK wealth arm in £1bn-plus deal

Private equity firms Warburg Pincus and Clayton Dubilier & Rice are in advanced talks to buy Canaccord Genuity’s UK wealth management arm for around £1bn, with HPS Investment Partners holding a minority stake. The deal underscores ongoing consolidation in wealth management as groups seek recurring revenue and scale amid regulatory costs and DIY investing competition. Canaccord’s UK wealth unit serves clients with more than £250,000 in assets and accounts for a large share of the group’s wealth revenues, though the sale remains uncertain as other bidders could emerge.

via Financial Times|

#canaccord-genuity-wealth-management-uk #clayton-dubilier-and-rice #mergers-and-acquisitions

business3 years ago•7 min saved

Baxter Sells BioPharma Solutions Business for $4.25B.

Baxter International has signed a definitive agreement to sell its BioPharma Solutions (BPS) business to Advent International and Warburg Pincus for $4.25bn in cash. The deal is expected to close in H2 2023, subject to regulatory approvals. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades. As a standalone company and in partnership with Advent and Warburg Pincus, BPS will operate as a premier, independent end-to-end CDMO providing a range of services for clients, from clinical research to commercial deployment.

via Baxter|

#advent-international #baxter-international #biopharma-solutions

business3 years ago•1 min saved

Warburg and Advent Leading Bid for Baxter's Biopharma Unit in Multi-Billion Dollar Deal

Private equity firms Warburg Pincus and Advent International are in advanced talks to acquire Baxter International's biopharma solutions business in a deal that could reach or exceed $4 billion. The buyout consortium has turned to other private equity firms to help fund the deal as direct lenders. Baxter may still opt to sell to another bidder or keep the business. Baxter's biopharma solutions unit supports drugmakers in the formulation, development and commercialization of drugs typically given by infusion or injection, such as biologics and vaccines.

via Reuters|

#advent-international #baxter-international #biopharma